Related Experiment Videos
[Familial well-differentiated thyroid carcinoma].
Voprosy Onkologii
|May 24, 2006
Summary
Familial thyroid cancer, particularly papillary thyroid carcinoma (PTC), occurs in 4.3% of cases and often involves inheritance from the mother. Genetic analysis revealed RET-protooncogene mutations in familial PTC.
Area of Science:
- Oncology
- Genetics
- Endocrinology
Context:
- Familial thyroid cancer represents a significant subset of thyroid malignancies.
- Understanding the genetic basis and clinical characteristics of familial thyroid cancer is crucial for risk assessment and management.
- Well-differentiated thyroid carcinoma (WDTC) includes papillary thyroid carcinoma (PTC), follicular, and medullary subtypes.
Purpose:
- To investigate the prevalence and clinical characteristics of familial thyroid cancer.
- To identify potential genetic mutations associated with familial thyroid cancer.
- To compare familial and sporadic thyroid cancer cases.
Summary:
- A study identified familial thyroid cancer in 4.3% of 1,118 patients with WDTC, with papillary thyroid carcinoma being the most common type (86%).
- Inheritance from the mother was most frequent (75%). Familial cases showed a higher incidence of concomitant thyroid pathology compared to sporadic cases.
- Molecular-genetic analysis of familial papillary thyroid carcinoma identified a RET-protooncogene mutation in codon 891 (exon 15) in affected mother-daughter pairs, while no BRAF mutations were found.
Impact:
- This research highlights the importance of considering family history in thyroid cancer diagnosis and management.
- Identifying the RET-protooncogene mutation provides insights into the genetic etiology of familial thyroid cancer.
- The findings may contribute to improved genetic counseling and targeted screening strategies for families with a history of thyroid cancer.